U.S. Markets closed

Canbiola, Inc. (CANB) Streamlines Its Supply Chain, Allowing a Nearly 30% Price Reduction Across all Product Lines

HICKSVILLE, NY / ACCESSWIRE / January 29, 2018 / Canbiola, Inc. (OTC PINK: CANB) is announcing that it has signed a contract that allows it to take total control of its supply chain, cutting out the middle-man and third-party manufacturing fees. ''We're now in control of our raw materials procurement and manufacturing process, which is expected to reduce the company's overall operating expenses while maintaining its profit margins. The new deal allows the company to fulfill its mission to improve the quality and costs of our products for our customers,'' says Marco Alfonsi, Canbiola, CEO.

''Our products benefit our clients with a variety of health issues, naturally, but the industry cost is high and reducing our overall production costs allows us to decrease our retail prices to customers and increase our market share. Canbiola is committed to bringing the highest quality products in the most cost-effective way to its customers, something we believe is beneficial to all. Our customers will get more for their hard-earned money and the company should benefit through solid growth in revenues and profit because of these new hypercompetitive prices,'' Mr. Alfonsi concludes.

Canbiola is always striving to make our products available to all who want to lead a lifestyle free of traditional medicine and the intake of prescription drugs. It's our belief that our customers always come first and foremost. New prices are now in effect and our web store can be found at https://canbiola.com/shop-all/.

About Canbiola, Inc.

Canbiola, Inc. is a public company trading under symbol CANB.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD industry. The company has already launched several products found at www.canbiola.com. It should be noted that cannabis is currently federally illegal and has been legalized for medical purposes in some form in only a limited number of states; however, the company's CBD is sourced from industrial hemp, which is thought to be permissible under federal law when product contents contain less than 0.03% THC.

The company also owns two technological solutions, WRAPmail (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at broker-dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance.

Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words ''anticipate,'' ''believe,'' ''estimate,'' ''may,'' ''intend,'' ''expect,'' and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to many risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

Contact Information:

Canbiola Investor Relation
Email: IR@canbiola.com
Phone: (516) 595-9544
Website: http://www.canbiola.com
Follow us on Twitter and Facebook

SOURCE: Canbiola, Inc.